Chaim Sheba Medical Center ( Site 0041)

Ramat Gan 5262000

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Melanoma

Studies at this site

• Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011) — Stopped early